Tempus AI/$TEM

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Ticker

$TEM
Sector
Primary listing

Employees

2,400

Tempus AI Metrics

BasicAdvanced
$15B
-
-$1.18
-
-

Bulls say / Bears say

Tempus exceeded Q1 2025 revenue expectations with a 75.4% year-over-year rise to $255.7 million and raised its full-year 2025 outlook to $1.25 billion, aiming for positive Adjusted EBITDA, signaling strong financial momentum (Investing.com turn11search1).
The company announced multi-year partnerships with AstraZeneca and Pathos to develop the largest multimodal foundation model in oncology, securing $200 million in data licensing and model development fees, underlining significant demand for its AI-driven platform (Reuters turn5view0).
Tempus signed a deal with Boehringer Ingelheim on May 14, 2025, granting access to its de-identified molecular, clinical, and imaging datasets via the Lens AI platform for cancer R&D, broadening its high-value pharmaceutical partnerships (Investing.com turn7search1).
Shares dropped 16.9% pre-market after Tempus posted Q4 revenue of $200.7 million, below the $203.1 million expected by analysts, highlighting operational risks and market sensitivity (Reuters turn10search6).
A report by short-seller Spruce Point led to a 16.4% share decline, alleging aggressive accounting practices, financial engineering, related-party deals, and warned of a possible 50–60% downside risk due to questionable earnings quality (Reuters turn8search3).
Spruce Point also noted that AI Applications revenue was only $12.4 million in 2024—less than 2% of total revenue—raising doubts about Tempus’s AI-driven growth story (Investing.com turn8search1).
Data summarised monthly by Lightyear AI. Last updated on 3 Sept 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $TEM

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs